The aim of this investigation was to perform a systematic review and meta-analysis to determine the efficacy of the acute ingestion of caffeine (from 3 to 6 mg/kg) to increase performance on variables related to team sports. A systematic review was performed in scientific databases from January to April 2018. All studies included had cross-over experimental designs comparing caffeine to an identical placebo condition. A meta-analysis was performed using the random effects model and pooled standardized mean differences (Glass’s Δ). Thirty-four studies published between 2001 and 2018 were included in the analysis. The meta-analysis revealed that caffeine increased single (Δ;95% confidence intervals = 0.19;0.14–0.25; p < 0.01) and repeated jump height (0.29;0.16–0.42; p < 0.01), single (0.16;0.02–0.30; p = 0.03) and repeated sprint velocity (0.14;0.03–0.25; p = 0.02), and reduced the time to complete agility tests (0.41;0.04–0.77; p = 0.03). During team sport matches, caffeine increased total running distance (0.41;0.20–0.62; p < 0.01), distance covered at sprint velocity (0.36;0.12–0.59; p < 0.01) and the number of sprints (0.44;0.18–0.69; p < 0.01). The acute ingestion of a moderate dose of caffeine had a small but significant positive effect on several aspects related to physical performance in team sports.

The ergogenic effect of acute caffeine ingestion has been widely investigated; however, scientific information regarding tolerance to the performance benefits of caffeine, when ingested on a day-to-day basis, is scarce. The aim of this investigation was to determine the time course of tolerance to the ergogenic effects of a moderate dose of caffeine. Eleven healthy active participants took part in a cross-over, double-blind, placebo-controlled experiment. In one treatment, they ingested 3 mg/kg/day of caffeine for 20 consecutive days while in another they ingested a placebo for 20 days. Each substance was administered daily in an opaque unidentifiable capsule, and the experimental trials started 45 min after capsule ingestion. Two days before, and three times per week during each 20-day treatment, aerobic peak power was measured with an incremental test to volitional fatigue (25 W/min) and aerobic peak power was measured with an adapted version of the Wingate test (15 s). In comparison to the placebo, the ingestion of caffeine increased peak cycling power in the incremental exercise test by ~4.0 ±1.3% for the first 15 days (P<0.05) but then this ergogenic effect lessened. Caffeine also increased peak cycling power during the Wingate test on days 1, 4, 15, and 18 of ingestion by ~4.9 ±0.9% (P<0.05). In both tests, the magnitude of the ergogenic effect of caffeine vs. placebo was higher on the first day of ingestion and then progressively decreased. These results show a continued ergogenic effect with the daily ingestion of caffeine for 15–18 days; however, the changes in the magnitude of this effect suggest progressive tolerance.

The objective of this study is to determine the effects of a caffeine-containing energy drink on female volleyball players' performance. Thirteen elite female volleyball players ingested 3 mg·kg of caffeine with an energy drink or the same drink without caffeine (placebo drink) in a double-blind and randomized study. Then, participants performed the following: standing spike, jumping spike, spike jump, blocking jump, squat jump, countermovement jump, manual dynamometry, and the agility t-test. A simulated volleyball game was played, videotaped, and notated afterward. In comparison to the placebo drink, the ingestion of the caffeinated energy drink increased the ball velocity in the standing spike (19.2 ± 2.1 vs 19.7 ± 1.9 m·s, P = 0.023) and in the jumping spike (17.9 ± 2.2 vs 18.8 ± 2.2 m·s, P = 0.038) and the jump height in the squat jump (28.1 ± 3.2 vs 29.4 ± 3.6 cm, P = 0.028), countermovement jump (32.0 ± 4.6 vs 33.1 ± 4.5 cm, P = 0.018), spike jump (43.3 ± 4.7 vs 44.4 ± 5.0 cm, P = 0.025), and block jump (35.2 ± 5.1 vs 36.1 ± 5.1 cm, P = 0.044). Furthermore, the caffeinated energy drink decreased the time needed to complete the agility t-test (11.1 ± 0.5 vs 10.9 ± 0.3 s, P = 0.036). During the game, the volleyball actions categorized as successful were more frequent with the caffeinated energy drink (34% ± 9% vs 45% ± 9%, P < 0.001), whereas imprecise actions decreased (28% ± 7% vs 14% ± 9%, P < 0.001) when compared with the placebo drink. Commercially available energy drinks can significantly improve physical performance in female volleyball players. Increased physical performance led to improved accuracy during an actual volleyball match.

The use of caffeine containing energy drinks has dramatically increased in the last few years, especially in the sport context because of its reported ergogenic effect. The ingestion of low to moderate doses of caffeinated energy drinks has been associated with adverse side effects such as insomnia or increased nervousness. The aim of the present study was to assess psycho-physiological changes and the prevalence of side effects resulting from the ingestion of 3 mg caffeine/kg body mass in the form of an energy drink. In a double-blind and placebo controlled experimental design, ninety experienced and low-caffeine-consuming athletes (fifty-three male and thirty-seven female) in two different sessions were provided with an energy drink that contained 3 mg/kg of caffeine or the same decaffeinated energy drink (placebo; 0 mg/kg). At 60 min after the ingestion of the energy drink, participants completed a training session. The effects of ingestion of these beverages on psycho-physiological variables during exercise and the rate of adverse side effects were measured using questionnaires. The caffeinated energy drink increased self-perceived muscle power during exercise compared with the placebo beverage (6·41 (sd1·7)v.5·66 (sd1·51);P= 0·001). Moreover, the energy drink produced a higher prevalence of side effects such as insomnia (31·2v.10·4 %;P< 0·001), nervousness (13·2v.0 %;P= 0·002) and activeness (16·9v.3·9 %;P= 0·007) than the placebo energy drink. There were no sex differences in the incidence of side effects (P>0·05). The ingestion of an energy drink with 3 mg/kg of caffeine increased the prevalence of side effects. The presence of these side effects was similar between male and female participants.

There are no scientific data about the effects of caffeine intake on volleyball performance. The aim of this study was to investigate the effect of a caffeine-containing energy drink to enhance physical performance in male volleyball players. A double-blind, placebo-controlled, randomized experimental design was used. In 2 different sessions separated by 1 wk, 15 college volleyball players ingested 3 mg of caffeine per kg of body mass in the form of an energy drink or the same drink without caffeine (placebo). After 60 min, participants performed volleyball-specific tests: standing spike test, maximal squat jump (SJ), maximal countermovement jump (CMJ), 15-s rebound jump test (15RJ), and agility T-test. Later, a simulated volleyball match was played and recorded. In comparison with the placebo drink, the ingestion of the caffeinated energy drink increased ball velocity in the spike test (73 ± 9 vs 75 ± 10 km/h, P < .05) and the mean jump height in SJ (31.1 ± 4.3 vs 32.7 ± 4.2 cm, P < .05), CMJ (35.9 ± 4.6 vs 37.7 ± 4.4 cm, P < .05), and 15RJ (29.0 ± 4.0 vs 30.5 ± 4.6 cm, P < .05). The time to complete the agility test was significantly reduced with the caffeinated energy drink (10.8 ± 0.7 vs 10.3 ± 0.4 s, P < .05). In addition, players performed successful volleyball actions more frequently (24.6% ± 14.3% vs 34.3% ± 16.5%, P < .05) with the ingestion of the caffeinated energy drink than with the placebo drink during the simulated game. A caffeine-containing energy drink, with a dose equivalent to 3 mg of caffeine per kg body mass, might be an effective ergogenic aid to improve physical performance and accuracy in male volleyball players.